ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,534,181 | +317.5% | 146,989 | +287.1% | 0.00% | +100.0% |
| Q2 2023 | $2,044,140 | +46.9% | 37,974 | +8.4% | 0.00% | – |
| Q1 2023 | $1,391,749 | -0.2% | 35,039 | +1.1% | 0.00% | – |
| Q4 2022 | $1,394,170 | +30.3% | 34,655 | +4.1% | 0.00% | – |
| Q3 2022 | $1,070,000 | +10.3% | 33,284 | +1.9% | 0.00% | – |
| Q2 2022 | $970,000 | +18.1% | 32,672 | +11.9% | 0.00% | – |
| Q1 2022 | $821,000 | -37.8% | 29,195 | +2.1% | 0.00% | – |
| Q4 2021 | $1,319,000 | +64.5% | 28,605 | +17.0% | 0.00% | – |
| Q3 2021 | $802,000 | -67.0% | 24,440 | -64.7% | 0.00% | -100.0% |
| Q2 2021 | $2,429,000 | +13.2% | 69,293 | +16.8% | 0.00% | 0.0% |
| Q1 2021 | $2,145,000 | +15.1% | 59,342 | -7.5% | 0.00% | 0.0% |
| Q4 2020 | $1,864,000 | +4.5% | 64,158 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $1,783,000 | -12.3% | 63,171 | +0.4% | 0.00% | 0.0% |
| Q2 2020 | $2,034,000 | -14.6% | 62,891 | +7.6% | 0.00% | 0.0% |
| Q1 2020 | $2,381,000 | -60.9% | 58,422 | -40.9% | 0.00% | -66.7% |
| Q4 2019 | $6,093,000 | -14.4% | 98,793 | +1.1% | 0.00% | -25.0% |
| Q3 2019 | $7,122,000 | -14.7% | 97,713 | -3.9% | 0.00% | -20.0% |
| Q2 2019 | $8,354,000 | -3.6% | 101,629 | -17.3% | 0.01% | -16.7% |
| Q1 2019 | $8,669,000 | +59.9% | 122,893 | +2.1% | 0.01% | +50.0% |
| Q4 2018 | $5,421,000 | -9.4% | 120,398 | +13.8% | 0.00% | 0.0% |
| Q3 2018 | $5,983,000 | +7.2% | 105,805 | +26.6% | 0.00% | 0.0% |
| Q2 2018 | $5,583,000 | +55.0% | 83,576 | +35.1% | 0.00% | +33.3% |
| Q1 2018 | $3,603,000 | -13.6% | 61,876 | -4.3% | 0.00% | 0.0% |
| Q4 2017 | $4,168,000 | +69.8% | 64,661 | +38.3% | 0.00% | +50.0% |
| Q3 2017 | $2,454,000 | +23.6% | 46,741 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $1,986,000 | +3.1% | 42,428 | +9.1% | 0.00% | 0.0% |
| Q1 2017 | $1,927,000 | +11.8% | 38,906 | +36.9% | 0.00% | 0.0% |
| Q4 2016 | $1,723,000 | -3.4% | 28,417 | +5.7% | 0.00% | 0.0% |
| Q3 2016 | $1,784,000 | +136.6% | 26,877 | +99.1% | 0.00% | +100.0% |
| Q2 2016 | $754,000 | +65.7% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $455,000 | -57.4% | 13,500 | -43.0% | 0.00% | 0.0% |
| Q4 2015 | $1,069,000 | +33.3% | 23,681 | +16.8% | 0.00% | 0.0% |
| Q3 2015 | $802,000 | -27.2% | 20,281 | +14.4% | 0.00% | -50.0% |
| Q2 2015 | $1,101,000 | +74.2% | 17,728 | +75.5% | 0.00% | +100.0% |
| Q1 2015 | $632,000 | +10.9% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $570,000 | +99.3% | 10,100 | 0.0% | 0.00% | – |
| Q3 2014 | $286,000 | -17.8% | 10,100 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $348,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |